Document is current
Any future updates will be listed below
-
Authors
Herrera-Restrepo, Oscar https://orcid.org/0000-0001-8193-999X
Packnett, Elizabeth https://orcid.org/0000-0002-4731-6956
Richards, Megan https://orcid.org/0000-0003-0737-389X
Kuylen, Elise https://orcid.org/0000-0002-3528-5507
Olaiya, Tosin O. https://orcid.org/0000-0002-5049-0111
Pinto, Thatiana https://orcid.org/0000-0002-0957-3118
Landgrave, Lindsay https://orcid.org/0000-0001-8954-9064
Ross, Ryan https://orcid.org/0000-0002-9316-5810
Allmon, Andrew G. https://orcid.org/0009-0004-6879-9231
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 10 December 2025
Accepted: 2 August 2026
First Online: 21 September 2026
Declarations
Conflict of interest: Oscar Herrera-Restrepo, Elise Kuylen, Tosin O. Olaiya, Thatiana Pinto, Lindsay C. Landgrave, and Andrew G. Allmon are employees of and hold financial equities in GSK. Elizabeth Packnett, Megan K. Richards, and Ryan Ross are employees of Merative, which was paid by GSK to conduct this study.
Ethics approval: This study was considered non-human subjects research and did not require informed consent, ethics committee, or Institutional Review Board review.
Data availability: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability: Not applicable.
Consent to participate: Not applicable.
Consent for publication: Not applicable.
Author contributions: Substantial contributions to study conception and design: OHR, EP, MR, EK, TO, LL, AGA; substantial contributions to analysis and interpretation of the data: OHR, EP, MR, EK, TO, TP, LL, RR, AGA; drafting the article or revising it critically for important intellectual content: OHR, EP, MR, EK, TO, TP, LL, RR, AGA; final approval of the version of the article to be published: OHR, EP, MR, EK, TO, TP, LL, RR, AGA.
